Rankings
▼
Calendar
SRPT Q3 2021 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$189M
+31.6% YoY
Gross Profit
$166M
87.6% margin
Operating Income
-$34M
-18.2% margin
Net Income
-$48M
-25.4% margin
EPS (Diluted)
$-0.60
QoQ Revenue Growth
+15.4%
Cash Flow
Operating Cash Flow
-$124M
Free Cash Flow
-$134M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$2.7B
Total Liabilities
$2.2B
Stockholders' Equity
$470M
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$189M
$144M
+31.6%
Gross Profit
$166M
$129M
+28.7%
Operating Income
-$34M
-$137M
+74.9%
Net Income
-$48M
-$196M
+75.5%
Revenue Segments
E X O N D Y S Fifty One
$116M
69%
A M O N D Y S Fourty Five
$27M
16%
V Y O N D Y S Fifty Three
$25M
15%
← FY 2021
All Quarters
Q4 2021 →